PulseAugur
EN
LIVE 05:15:57
中文(ZH) 创新药板块表现活跃,机构:板块有望迎来新一轮估值修复机会

Innovation drug and power semiconductor sectors show strong momentum · 1 source tracked

The innovation drug sector is experiencing increased activity, driven by policy optimization, industry catalysts, and capital inflows. Analysts anticipate a new phase of valuation recovery for this sector as fundamental improvements and innovation outcomes materialize. Concurrently, the power semiconductor sector is poised for growth due to a confirmed second wave of price increases and a surge in AI-driven demand, with projections indicating sustained growth through 2027. AI

IMPACT AI demand is a key driver for the power semiconductor sector's growth, indicating its increasing influence on hardware markets.

RANK_REASON The item discusses market trends and analyst opinions on the innovation drug and power semiconductor sectors, rather than a specific event.

Read on 36氪 (36Kr) →

AI-generated summary · Google Gemini · from 1 sources. How we write summaries →

Innovation drug and power semiconductor sectors show strong momentum · 1 source tracked

COVERAGE [1]

  1. 36氪 (36Kr) TIER_1 中文(ZH) ·

    Innovative drug sector shows active performance, institutions: sector is expected to usher in a new round of valuation repair opportunities

    近期,在政策优化、产业催化以及资金回流等多重因素推动下,创新药板块表现活跃。机构认为,随着行业基本面持续改善、创新成果加快兑现,创新药板块有望迎来新一轮估值修复机会。数据显示,截至6月30日,多只创新药相关ETF近一周获得资金净流入。其中,广发中证创新药产业ETF近一周获得5.26亿元资金增持,广发中证香港创新药ETF、国泰上证科创板创新药ETF均获得超4亿元资金净流入,易方达中证创新药产业ETF、汇添富国证港股通创新药ETF等产品也均获得资金加仓。(证券时报)